VANCOUVER, BRITISH COLUMBIA--(Marketwire - November 08, 2010) - Tekmira Pharmaceuticals Corporation (TSX: TKM), a leader in RNA interference (RNAi) therapeutics, announced today that it will hold a conference call and webcast on Monday, November 15, 2010 at 1:30 pm Pacific Time (4:30 pm Eastern Time) to discuss third quarter 2010 operating results and to provide a corporate update.
About the Conference Call
To participate in the conference call, please dial 416-340-9432 or 1-888-340-9655. The call will be available for replay until November 29, 2010 by calling 416-695-5800 or 1-800-408-3053 and entering the code 6147860.
The live or archived webcast can also be accessed through the Company’s website at www.tekmirapharm.com.
About Tekmira
Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading LNP delivery technology to pharmaceutical partners. Tekmira has been working in the field of nucleic acid delivery for over a decade and has broad intellectual property covering LNPs. Further information about Tekmira can be found at www.tekmirapharm.com. Tekmira is based in Vancouver, B.C.
Contacts:
The Equicom Group - Investors
Adam Peeler
416-815-0700 x 225
apeeler@equicomgroup.com
Tekmira Pharmaceuticals Corporation
Ian Mortimer
Executive Vice President and Chief Financial Officer
604-419-3200
www.tekmirapharm.com
Longview Communications Inc. - Media
David Ryan
604-694-6031
dryan@longviewcomms.ca
